THC rescheduling process ‘already in motion’ as industry urged ‘to get ready to respond’ by Steve Jones April 2, 2026April 2, 2026 The medicinal cannabis industry must prepare to resist any rescheduling of THC amid a warning that […]
Court adjourns Montu case again as proceedings approach second anniversary by Steve Jones March 24, 2026March 25, 2026
Lancet clinical review paper: why absence of evidence is not evidence of absence by Andrew Proudfoot March 18, 2026March 18, 2026
Meet the appointed members of the scheduling committee who could shape THC’s regulatory future by Adam Sheldon and Steve Jones March 18, 2026March 19, 2026
Rec-style branding risks undermining the industry, warns Bioxyne CEO by Adam Sheldon March 12, 2026March 12, 2026
AHPRA ponders new guidance but stops short of confirming tougher crackdown on closed-loop models by Steve Jones March 10, 2026March 10, 2026
If the industry wants a stable and credible future, this is the time to help shape it by Clare Barker March 4, 2026April 28, 2026
AMCA and MCIA merger to complete in the coming days as CEO search begins by Adam Sheldon February 26, 2026March 2, 2026
